Chaomin Wang

机构：Tianjin Medical University Cancer Institute and Hospital

发表论文 9 篇 · 总被引 79 次 · h-index 6

代表论文

• Serum Carboxypeptidase N1 Serves as a Potential Biomarker Complementing CA15-3 for Breast Cancer (2020 · Anti-Cancer Agents in Medicinal Chemistry · 被引 13)
• Tumor-derived CCL15 regulates RNA m6A methylation in cancer-associated fibroblasts to promote hepatocellular carcinoma growth (2024 · Cancer Letters · 被引 11)
• Carpaine alleviates tendinopathy in mice by promoting the ubiquitin-proteasomal degradation of p65 via targeting the E3 ubiquitin ligase LRSAM1 (2023 · Phytomedicine · 被引 10)
• Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer (2022 · Cellular Oncology · 被引 10)
• Hepatocyte-specific C-C motif chemokine ligand 9 signaling promotes liver fibrosis progression in mice (2025 · Hepatology · 被引 9)
• Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer (2021 · Cancer Cell International · 被引 9)